Mahdavi-Roshan, Marjan
Salari, Arsalan
Vakilpour, Azin
Savar Rakhsh, Amir
Ghorbani, Zeinab http://orcid.org/0000-0003-4230-5710
Funding for this research was provided by:
Guilan University of Medical Sciences (97111302)
Article History
Received: 4 October 2021
Accepted: 20 October 2021
First Online: 6 November 2021
Declarations
:
: The current trial design was confirmed by the Cardiovascular Diseases Research Center, GUMS, with the research number of 97111302, and carried out under the Declaration of Helsinki guideline. Also, the ethics committee of GUMS ascertained the study procedures with the ethic number of IR.GUMS.REC.1397.485. Because of the ethical issues, the usual drug therapies were continued for all studied subjects. All included individuals were provided informed consent in written format.
: Not applicable.
: None of the authors have any conflict of interest to disclose.